Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape
Tumor-associated macrophages (TAMs) can directly clear tumor cells and enhance the phagocytic ability of immune cells. An abundance of TAMs at the site of the glioblastoma tumor indicates that TAM-targeting immunotherapy could represent a potential form of treatment for this aggressive cancer. Herei...
Main Authors: | Zide Wang, Hanlin Zhong, Xiaohong Liang, Shilei Ni |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1024921/full |
Similar Items
-
Natural Killer Cell-Based Immunotherapy against Glioblastoma
by: Takayuki Morimoto, et al.
Published: (2023-01-01) -
The immunosuppressive microenvironment and immunotherapy in human glioblastoma
by: Xuehua Zhang, et al.
Published: (2022-11-01) -
Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy
by: Chao Lin, et al.
Published: (2023-03-01) -
Immune Microenvironment in Glioblastoma Subtypes
by: Zhihong Chen, et al.
Published: (2018-05-01) -
Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies
by: Boyuan Huang, et al.
Published: (2023-02-01)